AGEs	advanced glycation end products
CAD	coronary artery disease
CO	cardiac output
CD36	cluster of differentiation 36
cGMP	cyclic guanosine monophosphate
CRP	C-reactive protein
DAMPs	damage-associated molecular patterns
ECM	extracellular matrix
EF	ejection fraction
eNOS	endothelial nitric oxide synthase
ET-1	endothelin-1
Fpassive	cardiomyocyte passive stiffness
HSCs	hemopoietic stem cells
HF	heart failure
HFmrEF	heart failure with mid-range EF
HFpEF	heart failure with preserved EF
HFrEF	heart failure with reduced EF
HSPs	heat shock proteins
ICAM	intercellular adhesion molecule
IL-6	interleukin-6
IGF-1	insulin-like growth factor 1
LOX	lysyl-oxidase
MAPK	mitogen-activated kinase
MMPs	matrix metalloproteinases
NFκB	nuclear factor kappa-B
N2Bus	titin isoform N2B unique sequence
NCX	Na+/Ca2+ exchanger
NO	nitric oxide
PEVK	titin region rich in proline, glutamate, valine, and lysine
PKA	protein kinase A
PKG	protein kinase G activity
PP1	protein phosphatase 1
PP2a	protein phosphatases 2a
PRR	pathogen recognition receptor
IFN	type I interferon
RAGE	receptor for advanced glycation end products
SERCA2a	Ca2+ ATPase 2a
SR	sarcoplasmic reticulum
STEMI	ST-segment elevation MI
TAC	transverse aortic constriction
TIMP-1	tissue inhibitors of matrix proteinase 1
T1DM	type 1 diabetes mellitus
T2DM	type 2 diabetes mellitus
TGFβ	transforming growth factor β
TSP-1	thrombospondin-1
TNF-α	tumour necrosis factor alpha
VM	viral myocarditis